|Articles|June 26, 2011

Sulfonylurea monotherapy ups CVD risk vs. metformin in older diabetics

Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.

Related to this article

Is late-night eating hurting your liver?: ©Nalidsa - stock.adobe.com
An Oregon Health & Science University-led analysis of nearly 200,000 people found a 20% to 30% higher rate of fatty liver disease and cirrhosis among those who reported eating after dinner or after bedtime.